The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our products and product candidates in the US or other countries, if approved, which could have a material adverse effect on our results of operations and financial condition.
All entries for: Crinetics Pharmaceuticals Inc.
February 26, 2026
Crinetics Pharmaceuticals Inc.
Neutral Outlook
San Diego, CA
501-1,000 employees
While we do not believe that the IRA or its effects will impact our ability to obtain patents in the near future, we cannot be certain whether it will affect our patent strategy in the long run.
Disease Area: Endocrinology, Oncology, Rare Diseases
Drug Type: Biologic, Small Molecule